ADCT
Price
$2.75
Change
-$0.10 (-3.51%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
282.8M
48 days until earnings call
IMNM
Price
$8.68
Change
-$0.24 (-2.69%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
776.15M
49 days until earnings call
Interact to see
Advertisement

ADCT vs IMNM

Header iconADCT vs IMNM Comparison
Open Charts ADCT vs IMNMBanner chart's image
ADC Therapeutics SA
Price$2.75
Change-$0.10 (-3.51%)
Volume$6.6K
Capitalization282.8M
Immunome
Price$8.68
Change-$0.24 (-2.69%)
Volume$83.58K
Capitalization776.15M
ADCT vs IMNM Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. IMNM commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Buy and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ADCT: $2.85 vs. IMNM: $8.92)
Brand notoriety: ADCT and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 116% vs. IMNM: 51%
Market capitalization -- ADCT: $282.8M vs. IMNM: $776.15M
ADCT [@Biotechnology] is valued at $282.8M. IMNM’s [@Biotechnology] market capitalization is $776.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 4 bearish.
  • IMNM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ADCT is a better buy in the short-term than IMNM.

Price Growth

ADCT (@Biotechnology) experienced а -12.58% price change this week, while IMNM (@Biotechnology) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($776M) has a higher market cap than ADCT($283M). ADCT YTD gains are higher at: 43.216 vs. IMNM (-16.008). ADCT has higher annual earnings (EBITDA): -95.64M vs. IMNM (-175.18M). IMNM has more cash in the bank: 317M vs. ADCT (195M). IMNM has less debt than ADCT: IMNM (4.77M) vs ADCT (123M). ADCT has higher revenues than IMNM: ADCT (75.8M) vs IMNM (10.9M).
ADCTIMNMADCT / IMNM
Capitalization283M776M36%
EBITDA-95.64M-175.18M55%
Gain YTD43.216-16.008-270%
P/E RatioN/AN/A-
Revenue75.8M10.9M695%
Total Cash195M317M62%
Total Debt123M4.77M2,579%
TECHNICAL ANALYSIS
Technical Analysis
ADCTIMNM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLACX4.610.07
+1.54%
NYLI Winslow Large Cap Growth Class C
NALFX70.75N/A
N/A
New Alternatives A
NBRAX25.20N/A
N/A
Neuberger Berman M/C Intrinsic Val A
WRHIX5.85N/A
N/A
Macquarie High Income Fund Class C
MRAGX31.82N/A
N/A
Meridian Growth A

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+6.34%
QTTB - ADCT
48%
Loosely correlated
+3.92%
VTYX - ADCT
44%
Loosely correlated
+0.42%
IMNM - ADCT
41%
Loosely correlated
+2.06%
OVID - ADCT
40%
Loosely correlated
+4.03%
CLRB - ADCT
40%
Loosely correlated
+8.57%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+2.06%
IDYA - IMNM
61%
Loosely correlated
+1.68%
BEAM - IMNM
55%
Loosely correlated
+2.63%
RXRX - IMNM
54%
Loosely correlated
+8.07%
SYRE - IMNM
54%
Loosely correlated
+4.97%
ARWR - IMNM
53%
Loosely correlated
+2.90%
More